Monkeypox Vaccine: U.S. Falls Short of Overwhelming Demand - MedicineNet Health News

  • 📰 MedicineNet
  • ⏱ Reading Time:
  • 29 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

US can't keep up with demand for monkeypox vaccine.

. It can spread through kissing, sex and body contact. Exposure to unwashed laundry contaminated by the virus could also lead to infection, as could extended face-to-face contact with a sick individual.

The CDC said commercial laboratories are developing tests for the virus, including the Mayo Clinic in Minneapolis, which will be accepting samples from around the country for testing purposes as early as this week. “This will not only increase testing capacity, but also make it more convenient for providers and patients to access tests by using existing provider-to-laboratory networks,” CDC Director Dr. Rochelle Walensky said in aThe fact that the disease has so far infected predominantly gay men has prompted new concerns over stigmatizing LGBTQ+ populations.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 575. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New York City to open more Monkeypox vaccine appointmentsThe New York City Health Department will make 8,200 monkeypox vaccine appointments available starting Friday. Why are all these men so desperate for a vaccine...are they really this promiscuous in this community 🙄
Source: ABC7NY - 🏆 592. / 51 Read more »

New Omicron Subvariant Is Spreading in India, U.S. - MedicineNet Health NewsAs the coronavirus continues to evolve, a new highly contagious Omicron variant is appearing in India and other nations, including the United States, experts say.
Source: MedicineNet - 🏆 575. / 51 Read more »

Novavax's protein-based vaccine approval fails to boost stock as demand in U.S. for shots and boosters remains lowU.S. health regulators authorized the use of Novavax’s COVID-19 vaccine, providing a new option that works differently than the two leading vaccines based on mRNA technology, but the move comes at a time when uptake of shots and boosters is low.
Source: MarketWatch - 🏆 3. / 97 Read more »